Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank8
3Y CAGR-40.3%
5Y CAGR-18.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-40.3%/yr
vs -18.1%/yr prior
5Y CAGR
-18.7%/yr
Recent deceleration
Acceleration
-22.2pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $332009.00 | +17.3% |
| 2025 | $283128.00 | -91.0% |
| 2024 | $3.16M | +102.4% |
| 2023 | $1.56M | +4.9% |
| 2022 | $1.49M | +58.8% |
| 2021 | $936127.00 | -46.7% |
| 2020 | $1.76M | -49.4% |
| 2019 | $3.47M | -10.9% |
| 2018 | $3.89M | -30.8% |
| 2017 | $5.63M | - |